Management of Steroid-Refractory Immune-Related Adverse Events.

Management of Steroid-Refractory Immune-Related Adverse Events. Oncology (Williston Park). 2019 Aug 23;33(8): Authors: Watson ML, Beardslee T PMID: 31469899 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31469899?dopt=Abstract

Source: Oncology (Williston Park, N.Y.) - August 22, 2019 Category: Cancer & Oncology Authors: Watson ML, Beardslee T Tags: Oncology (Williston Park) Source Type: research

More News: Cancer & Oncology